Derek Jones, Chief Executive of the Babraham Research Campus
On Wednesday 14 July 2021, bit.bio attended The Babraham Investor Conference 2021 (BIC), an event for investors focusing on early-stage and scale-up life science and med-tech companies. bit.bio Co-Founder Florian Schuster was the second scale-up speaker.
Derek Jones, Chief Executive of the Babraham Research Campus opened the event by outlining how the Campus directly impacts the investor community: “Research has shown that investors see a 7.2 x return on investments on average in Campus companies.”
Florian revealed how bit.bio is coding human cells for health, to precision engineer the next generation of medicine.
Florian Schuster Co-Founder, CFO and COO bit.bio said:
“We are solving the manufacturing problem of human cells which allows us to overcome the major problems our sector is currently facing: the reproducibility issues in scientific research, the translational gap in drug development, and to make cell therapies consistent and scalable.”
bit.bio has raised more than £50 million in seed and Series A funding.